[JS03★☆] Immunotoxicity for Drug Development and Clinical Applications

11:05 AM - 11:30 AM JST(2:05 AM - 2:30 AM UTC)

[JS03-5] Discussion and proposals from the Japanese Society of Immunotoxicology toward the revision of ICH S8 guideline

○Tetsuya Sakairi¹ (1. Tanabe Pharma Corp.)